Oral vs. intravenous chemotherapy: How do they compare?

Part 1 of this article focused on comparing newer oral oncolytics to older ones in chronic myelogenous leukemia, advanced kidney cancer, medullary thyroid cancer, and metastatic melanoma. Now, part 2 focuses on comparing newer oral chemotherapies to current intravenous chemotherapy. » More

Antibiotic formulary guidelines for health systems: Balancing evidence and stewardship

Even with a dearth of new antibiotics, health systems should vigilantly evaluate their antibiotic formularies. » More

Better adherence, lower healthcare costs for diabetes patients enrolled in value-based insurance designs

A recent study, coordinated by the Florida Health Care Coalition, with primary analysis conducted by Truven Health Analytics, expands the current research efforts on value-based insurance design. » More

Location helps determine access to affordable, quality healthcare for Americans

For healthcare consumers, low household income need not condemn them to low quality, but high income is not the panacea either. A state scorecard released in September by the Commonwealth Fund indicated that the wide differences in healthcare experiences found in a state-by-state comparison often put higher-income as well as low-income families at risk. » More

Some opioids linked to certain birth defects

Women taking opioids just before or during early pregnancy are 2 times more likely to have a pregnancy affected by a neural tube defect, such as spina bifida, according to a study published online September 9 in Obstetrics & Gynecology in advance of the October 2013 print issue. » More

Downloads

You are subscribed to the Formulary Issue Alert.

CDC seeks answers on e-cigarettes

FDA actions in brief

For children, skipped medications often lead to emergency department visits

Orphan drug development for biotechs